High discontinuation rate of natalizumab in JC virus seropositive patients due to significant anxiety and safety feelings

被引:5
作者
Alroughani, R. [1 ,2 ]
机构
[1] Amiri Hosp, Dept Med, Div Neurol, Sharq 13041, Kuwait
[2] Dasman Diabet Inst, Neurol Clin, Kuwait, Kuwait
关键词
D O I
10.1177/1352458514526945
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1667 / 1668
页数:2
相关论文
共 2 条
[1]   Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings [J].
Rinaldi, F. ;
Seppi, D. ;
Calabrese, M. ;
Perini, P. ;
Gallo, P. .
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (11) :1640-1643
[2]   Safety, anxiety and natalizumab continuation in JC virus-seropositive MS patients [J].
van Rossum, Johannis A. ;
Vennegoor, Anke ;
Balk, Lisanne ;
Uitdehaag, Bernard M. ;
Polman, Chris H. ;
Killestein, Joep .
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (01) :108-111